Lactobacillus salivarius and L. gasseri down-regulate Aggregatibacter actinomycetemcomitans exotoxins expression

Annals of Microbiology

Volumn 64, Issue 2, 2014, Pages 611-617

  Nissen, Lorenzo ^a   Sgorbati, Barbara ^a   Biavati, Bruno ^a   Belibasakis, Georgios N ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cytolethal distending toxin; Leukotoxin; Oral cavity; Periodontal disease; Probiotics

Indexed keywords

EID: 84901638772     PISSN: 15904261     EISSN: 18692044     Source Type: Journal    
DOI: 10.1007/s13213-013-0694-x     Document Type: Article

References (39)

1. Alpay Karaoglu S, Aydin F, Kilic SS, Kilic AO (2003) Antimicrobial activity and characteristics of bacteriocins produced by vaginal lactobacilli. Turk J Med Sci 33:7-13
2. Badet C, Thebaud NB (2008) Ecology of lactobacilli in the oral cavity: a review of literature. Open Microbiol J 2:38-48
3. Belibasakis GN, Reddi D, Bostanci N (2011a) Porphyromonas gingivalis induces RANKL in T-cells. Inflammation 34(2):133-138
4. Belibasakis GN, Meier A, Guggenheim B, Bostanci N (2011b) Oral biofilmchallenge regulates the RANKL-OPGsystemin periodontal ligament and dental pulp cells. Microb Pathog 50(1):6-11
5. Chatterjee S, Asakura M, Chowdhury N, Neogi SB, Sugimoto N, Haldar S, Awasthi SP, Hinenoya A, Aoki S,Yamasaki S (2010) Capsaicin, a potential inhibitor of cholera toxin production in Vibrio cholerae. FEMS Microbiol Lett 306(1):54-60
6. Chen T, Yu W-H, Izard J, Baranova OV, Lakshmanan A, Dewhirst FE (2010) The human oral microbiome database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database No. doi:10.1093/DATABASE/BAQ013
7. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CGM (2007) Bacteriocin production as a mechanism for the anti-infective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci USA 104(18):7617-7621
8. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner ACR, Yu W-H, Lakshmanan A, Wade WG (2010) The human oral microbiome. J Bacteriol 192(19):5002-5017
9. Fine DH, Kaplan JB, Kachlany SC, Schreiner HC (2006) How we got attached to Actinobacillus actinomycetemcomitans: a model for infectious diseases. J Periodontol 42:114-157
10. Guggenheim B, Giersten E, Schupbach P, Shapiro S (2001) Validation of an in vitro biofilm model of supragingival plaque. J Dent Res 80(1):363-370
11. Handfield M, Mans JJ, Zheng G, Lopez MC, Mao S, Progulske-Fox A, Narasimhan G, Baker HV, Lamont RJ (2005) Distinct transcriptional profiles characterize oral epithelium microbiota interactions. Cell Microbiol 7(6):811-823
12. Hasegawa Y, Mans JJ, Mao S, Lopez MC, Baker HV, Handfield M, Lamont RJ (2007) Gingival epithelial cell transcriptional responses to commensal and opportunistic oral microbial species. Infect Immun 75:2540-2547
13. Haubek D (2010) The highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans: evolutionary aspects, epidemiology and etiological role in aggressive periodontitis. APMIS Suppl 130:1-53
14. Henderson B, Ward JM (2000) Ready D (2010) Aggregatibacter (Actinobacillus) actinomycetemcomitans: a triple A periodontopathogen? Periodontology 54(1):78-105
15. Hojo K, Mizoguchi C, Taketomo N, Ohshima T, Gomi K, Arai T,Maeda N (2007) Distribution of salivary Lactobacillus and Bifidobacterium species in periodontal health ad disease. Biosci Biotech Biochem 71(1):152-157
16. Isaza MP, Duncan MS, Kaplan JB, Kachlany SC (2008) Screen for Leukotoxin mutants in Aggregatibacter actinomycetemcomitans: genes of the phosphotransferase system are required for Leukotoxin biosynthesis. Infect Immun 76(8):3561-3568
17. Ishikawa H, Aiba Y, NakanishiM, Oh-Hashi Y, Koga T (2003) Suppression of periodontal pathogenic bacteria in the saliva of humans by the administration of Lactobacillus salivarius TI2711. J Jpn Assoc Periodontol 45(1):105-112
18. Itoh T, Fujimoto Y, Kawai Y, Toba T, Saito T (1995) Inhibition of foodborne pathogenic bacteria by bacteriocins from Lactobacillus gasseri. Lett Appl Microbiol 21:137-141
19. Iwamoto T, Suzuki N, TanabeK, Takeshita T, Hirofuji T (2010) Effects of probiotic Lactobacillus salivarius WB21 on halitosis and oral health: an open-label pilot trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110:201-208
20. Kawamoto D, Ando ES, Longo PL, NunesACR,Wikstrom M, MayerMPA (2009) Genetic diversity and toxic activity of Aggregatibacter actinomycetemcomitans isolates. Oral Microbiol Immunol 24(6):493-501
21. Kawase M, He F, Kubota A, Miyazawa K, Yoda K, Hiramatsu M (2011) Strain-specific detection by pulsed-field gel electrophoresis of Lactobacillus gasseri TMC0356 in human faeces after oral administration of these organisms. Microbiol Immunol 55(8):589-594
22. Koll-Klais P, Mandar R, Leibur E, Marcotte H, Hammarstrom L, Mikelsaar M (2005) Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol 20(6):354-361
23. Kuehbacher T, Rehman A, Lepage P, Hellmig S, Folsch UR, Schreiber S, Otto SJ (2008) Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease. J Med Microbiol 52(12):1569-1576
24. Lazarevic V, Whiteson K, Huse S, Hernandez D, Farinelli L, Osteras M, Schrenzel J, Francois P (2009) Metagenomic study of the oral microbiota by Illumina high-throughput sequencing. J Microbiol Methods 79(3):266-271
25. Mantzourani M, Gilbert SC, Su Long HNH, Sheehy EC, Tank S, Fenlon M, BeightonD (2009a) The isolation of bifidobacteria from occlusal carious lesions in children and adults. Caries Res 43(4):308-313
26. Mantzourani M, Fenlon M, Beighton D (2009b) Association between Bifidobacteriaceae and the clinical severity of root caries lesions. Oral Microbiol Immunol 24(1):32-37
27. Matsumoto M, Tsuji M, Sasaki H, Fujita K, Nomura R, Nakano K, Shintani S, Oshima T (2005) Cariogenicity of the probiotic bacterium Lactobacillus salivarius in rats. Caries Res 39(6):479-483
28. Mayanagi G, Kimura M, Nakayama S, Hirata H, Sakamoto M, Benno Y, Shimauchi H (2009) Probiotics effect of orally administered Lactobacillus salivarius WB21-containing tablets on periodontipathic bacteria: a double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol 36:506-513
29. Meurman JH, Stamatova I (2007) Probiotics: contributions to oral health. Oral Dis 13(5):443-451
30. Nissen L, Chingwaru W, Biavati B, Sgorbati B, Cencic A (2009) Gut health promoting activity of new putative probiotic/protective Lactobacillus spp. strains: a functional study in the small intestinal cell model. Int J Food Microbiol 135(3):288-294
31. PhamLC, van Spanning RJM, RolingWFM, Prosperi AC, Terefework Z, ten Cate JM, Crielaard W, Zaura E (2009) Effects of probiotic Lactobacillus salivarius W24 on the compositional stability of oral microbial communities. Arch Oral Microbiol 54(2):132-137
32. Qiu J, ZhangX,LuoM, LiH, Dong J,Wang J, LengB,WangX, FengH, Ren W, Deng X (2011) Sub-inhibitory concentrations of perilla oil affect the expression of secreted virulence factor genes in Staphylococcus aureus. PLoS ONE 6(1):e16160. doi:10.1371/journal.pone.0016160
33. Raghavendran K, Mylotte JM (2000) Scannapieco FA (2007) Nursing home-associated pneumonia, hospital-acquired pneumonia and ventilator-associated pneumonia: the contribution of dental biofilms and periodontal inflammation. Periodontology 44:164-177
34. Robredo B, Torres C (2000) Bacteriocin production by Lactobacillus salivarius of animal origin. J Clin Microbiol 38(10):3908-3909
35. Shimauchi H, Mayanagi G, Nakaya S, Minamibuchi M, Ito Y, Yamaki K, Hirata H (2008) Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. J Clin Periodontol 35:897-905
36. Smith-Palmer A, Stewart J, Fyfe L (2004) Influence of sub-inhibitory concentrations of plant essential oils on the production of enterotoxins A and B and a-toxin by Staphylococcus aureus. J Med Microbiol 53:1023-1027
37. Stamatova I (2000) Meurman JH (2009) Probiotics and periodontal disease. Periodontology 51:141-151
38. Turnbaugh PJ, Ley RH, Hamady M, Fraser-Liggett CM,Knight R,Gordon JI (2007) The human microbiome project. Nature 449:804-811
39. Yamasaki S, Asakura M, Neogi SB, Hinenoya A, Iwaoka E, Aoki S (2011) Inhibition of virulence potential of Vibrio cholerae by natural compounds. Indian J Med Res 133(2):232-239